News brief­ing: Ve­rastem CMO ex­its two weeks af­ter join­ing com­pa­ny; Ther­mo Fish­er inks $550M M&A deal

Two weeks af­ter join­ing Ve­rastem On­col­o­gy as chief med­ical of­fi­cer, Frank Neu­mann is leav­ing the com­pa­ny for an­oth­er job.

Neu­mann had joined Ve­rastem af­ter leav­ing blue­bird bio, which sur­pris­ing­ly split in­to two com­pa­nies last week, one in on­col­o­gy and one in rare dis­eases. It’s not yet clear to where Neu­mann is head­ed next, but he not­ed in a state­ment that Ve­rastem’s da­ta and strat­e­gy were “tru­ly ex­cit­ing.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER